Develops microbiome-based drugs for type 1 diabetes and other autoimmune diseases.
| Date | Round | Amount |
|---|---|---|
| Oct 2023 | Pre Seed Amsterdam-based Advanced Microbiome Interventions received a EUR300K convertible loan from Innovatiefonds Noord-Holland for type 1 diabetes drug development. | $324K |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.